Sun Galaxy Pharmaceuticals Private Limited
About Sun Galaxy Pharmaceuticals Private Limited
Data last updated:
Sun Galaxy Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 17 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2012PTC230145.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sanjay Kumar Garg and Amit Garg.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office is at 2F S – 505 School Block Vikas Marg Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2015, the company reported a revenue of ₹17.29 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹60,957 (net margin -3.5%) and EBITDA of ₹1.85 Lakh (EBITDA margin 10.7%).
As per MCA filings, the company has open charges of ₹15 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Sun Galaxy Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered Address2F S – 505 School Block Vikas Marg Shakarpur, New Delhi, Delhi, India – 110092
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sun Galaxy Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sun Galaxy Pharmaceuticals Private Limited, buy the company report.
Financials of Sun Galaxy Pharmaceuticals Private Limited
FY 2015 filings availableSun Galaxy Pharmaceuticals Private Limited reported revenue of ₹17.29 Lakh (down 39% YoY) for FY 2015.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year. EBITDA fell 17% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹1.85 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹60,957 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | 10.7% |
| Net Profit Margin | -3.5% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Sun Galaxy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sun Galaxy Pharmaceuticals Private Limited
Sun Galaxy Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Garg | Director | 20 Oct 2014 | 12 Years 0 Months | Current |
| Amit Garg | Director | 17 Jan 2012 | 14 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2013 | 10419883 | Syndicate Bank | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sun Galaxy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sun Galaxy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sun Galaxy Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sun Galaxy Pharmaceuticals Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Archana Agarwal ceased to be Director on 20 Oct 2014.
Frequently asked questions
Sun Galaxy Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 17 January 2012 (14+ years old) and is registered under CIN U33110DL2012PTC230145.
Sun Galaxy Pharmaceuticals has 2 current directors:
- Sanjay Kumar Garg - Director
- Amit Garg - Director
The latest financial statements of Sun Galaxy Pharmaceuticals on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sun Galaxy Pharmaceuticals is U33110DL2012PTC230145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sun Galaxy Pharmaceuticals was incorporated on 17 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Archana Agarwal ceased to be Director on 20 Oct 2014. Sanjay Kumar Garg was appointed as Director on 20 Oct 2014. Amit Garg was appointed as Director on 17 Jan 2012.
The registered office of Sun Galaxy Pharmaceuticals is at 2F S – 505 School Block Vikas Marg Shakarpur, New Delhi, Delhi, India – 110092.
Sun Galaxy Pharmaceuticals operates in the trading industry, in the wholesale segment.
Sun Galaxy Pharmaceuticals has open charges of ₹15 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Sun Galaxy Pharmaceuticals is active non-compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
